View Section: Cash Flow Statement
CR
Crinetics Pharmaceuticals IncNASDAQ CRNX Stock Report
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
4.241
Middle
Exchange
XNAS - Nasdaq
CR
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
4.241
Exchange
XNAS - Nasdaq
CR
Ex-dividend date
Amount
Share price
Yield
This ticker has no dividend history